American Century Companies’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
O
ASP
RI
VC
FCMV
PA
American Century Companies's CRVS Position: Q2 2025 in Review
American Century Companies sold out of Corvus Pharmaceuticals (CRVS) in Q2 2025, closing a stake of 89,265 shares — an estimated $284K sold.
American Century Companies first reported a position in CRVS in Q3 2023 and held it in 7 quarters. The position peaked at $284K in Q1 2025. 92 funds tracked by Wall St. Rank hold CRVS as of Q2 2025.
- American Century Companies reported no remaining Corvus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- American Century Companies sold 89,265 Corvus Pharmaceuticals shares in Q2 2025, an estimated $284K.
- American Century Companies first reported a position in Corvus Pharmaceuticals in Q3 2023 and held it in 7 quarters.
- American Century Companies's Corvus Pharmaceuticals position peaked at $284K in Q1 2025.
- 92 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2025.
Based on American Century Companies's 13F filing for Q2 2025, filed 12 Aug 2025.